NANOVIRICIDES INC | 0,363 Euro | +0,015 +4,31 % | |
| WKN: A0F6Z7 ISIN: US6300871042 Ticker-Symbol: NV3 | Frankfurt | 14.12.12 | 15:34 Uhr |
Branche NanotechnologieAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 11.06. | NanoViricides Files Orphan Drug Application with the FDA for DengueCide | - | AZoNano | |
| 10.06. | NanoViricides could benefit from orphan drug status for tropical disease candidate | - | Proactive Investors | |
| 04.06. | NanoViricides' FluCide: a potential cure for the flu, drug to enter human trials next year | - | Proactive Investors | |
| 31.05. | NANOVIRICIDES, INC. - 8-K, Current Report | - | SEC Filings | |
| 29.05. | NanoViricides, Inc., To Present At The Second Annual Marcum LLP MicroCap Conference | 14 | PR Newswire | |
| WEST HAVEN, Conn., May 29, 2013 /PRNewswire/ --NanoViricides, Inc. (NNVC) announced today that Eugene Seymour, MD, MPH, Chief Executive Officer will present at the Second Annual Marcum LLP MicroCap... Mehr lesen zu: NanoViricides, Inc., To Present At The Second Annual Marcum LLP MicroCap Conference | ||||
| 28.05. | NanoViricides strengthens board with Baylor College professor | - | Proactive Investors | |
| 28.05. | Millions of Opportunities For NanoViricides Inc (OTCBB:NNVC) | - | HotStocked.com | |
| 22.05. | NanoViricides reports stronger cash position; sufficient for first clinical trials | 2 | Proactive Investors | |
| 21.05. | NanoViricides, Inc. (OTCBB:NNVC) Rises After Promotion | 1 | HotStocked.com | |
| 13.05. | NanoViricides strengthens management team with new interim CFO | - | Proactive Investors | |
| 25.04. | NanoViricides to Discuss its Broad Drug Pipeline at BIO International Convention | - | AZoNano | |
| 23.04. | NanoViricides' Oral and Injectable FluCide Drug Candidates May Be Effective against Novel H7N9 Strain | - | AZoNano | |
| 22.04. | NanoViricides shares rally on potential effective treatment for H7N9 virus | - | Proactive Investors | |
| 21.03. | NanoViricides to present at key BioPhysics seminar this week | 2 | Proactive Investors | |
| 06.03. | NanoViricides shares gain as it takes the lead at two sessions for the Symposium on Nanomedicines | 2 | Proactive Investors | |
| 01.03. | NanoViricides begins its cGMP clinical drug facility renovation | 1 | Pharma Bus Review | |
| 28.02. | NanoViricides armed with $18 mln of cash after retirement of Series C preferred stock | - | Proactive Investors | |
| 26.02. | NanoViricides starts renovation for pilot production and lab facility, shares rise | 1 | Proactive Investors | |
| 19.02. | NanoViricides says "strong" cash position can support clinical trials of influenza drugs | 1 | Proactive Investors | |
| 13.02. | NanoViricides to Participate in 15th Annual BIO CEO and Investor Conference | - | AZoNano | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| NOVAVAX | 1,415 | +0,21 % | NOVAVAX INC - 8-K, Current Report |
| APPLIED NANOTECH | 0,053 | 0 % | Applied Nanotech Retains Stybel Peabody for CEO Search / Boston-Based Firm Specializes in "Smooth Leadership Change" |
| DIVERSA | 0,008 | +33,33 % | DIVERSA LIMITED: Change of Director's Interest Notice |
| QUANTUM MATERIALS | 0,056 | +64,71 % | Quantum Materials Tetrapod Quantum Dots Break Kasha's Rule: Enhanced Performance Enables Commercialization of Novel Discovery |
| NANOPHASE TECHNOLOGIES | 0,203 | +0,50 % | Lowest Sales per Share in the Specialty Chemicals Industry Detected in Shares of Nanophase Technologies |
